CYFENDUS

STN: 125761
Proper Name: Anthrax Vaccine Adsorbed, Adjuvanted
Tradename: CYFENDUS
Manufacturer: Emergent BioDefense Operations Lansing LLC.
Indication:

• CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted) is a vaccine indicated for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs.
• The efficacy of CYFENDUS for post-exposure prophylaxis is based solely on studies in animal models of inhalational anthrax.

Product Information

Supporting Documents

• Content current as of:

  11/06/2025

Source